PLIN5 and diabetic cardiomyopathy: Therefore, Plin5 may serve as a bidirectional regulator for lipid turn over by phosphorylation modification and content variation in cardiomyocytes and act as a potential molecular target for the treatment of dyslipidemia in diabetic cardiomyopathy.